LEVI insider report: Jill Beraud acquires Class A and B dividend-equivalent rights
Rhea-AI Filing Summary
Jill Beraud, a director of Levi Strauss & Co. (LEVI), filed a Form 4 disclosing acquisitions on 08/08/2025. The filing reports the acquisition of 82 dividend equivalent rights (DERs) tied to Class A Common Stock at a reported price of $0.00; after the transaction she beneficially owned 172,616 Class A shares directly. The filing also reports acquisition of 97 DERs tied to Class B Common Stock (each Class B share convertible into one Class A share) at $0.00; the filing shows 14,095 derivative securities beneficially owned following the transaction.
The Form explains the 82 DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the underlying award, while the 97 DERs are fully vested and the underlying Class B shares issuable pursuant to those DERs are subject to a deferral delivery feature. The Form was filed by one reporting person and signed by an attorney-in-fact on 08/12/2025.
Positive
- Acquisition of 82 DERs tied to Class A Common Stock at $0.00 is explicitly disclosed
- Acquisition of 97 DERs tied to Class B Common Stock is explicitly disclosed and those DERs are fully vested
- Beneficial ownership after transactions is stated: 172,616 Class A shares (direct) and 14,095 derivative securities (direct)
Negative
- Some awarded DERs are reported at a $0.00 price, indicating grant issuance rather than market purchase
- Underlying Class B shares issuable pursuant to certain DERs are subject to a deferral delivery feature, which delays settlement of those shares
Insights
TL;DR: Director received stock-settled dividend equivalent rights and reported meaningful direct and derivative holdings.
The filing documents acquisitions on 08/08/2025 of equity-settled dividend equivalent rights (DERs) recorded at a $0.00 price, which is consistent with compensation grants rather than open-market purchases. Post-transaction holdings are explicit: 172,616 Class A shares directly and 14,095 derivative securities directly. These entries are primarily disclosure of compensation-related awards and do not by themselves indicate trading activity or sales. The convertibility note for Class B shares and the deferral delivery feature are material for timing of settlement but are disclosed as contractual terms rather than executed transfers.
TL;DR: Grants include explicit vesting and deferral terms; disclosure aligns with executive/director compensation reporting norms.
The Form 4 specifies vesting mechanics: the 82 DERs vest in full by the earlier of the day before the next annual meeting or one year after grant, while 97 DERs are fully vested but subject to a deferral delivery feature. These provisions affect when shares may be delivered to the reporting person and are relevant to governance oversight of equity compensation timing. The filing was executed by an attorney-in-fact and filed by a single reporting person, indicating standard administrative processing of insider award reporting.